These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 9482108

  • 1. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R, Torà M, Díaz VM, Real FX.
    Oncogene; 1998 Feb 05; 16(5):625-33. PubMed ID: 9482108
    [Abstract] [Full Text] [Related]

  • 2. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, Booyse FM.
    Alcohol Clin Exp Res; 2001 Feb 05; 25(2):163-70. PubMed ID: 11236828
    [Abstract] [Full Text] [Related]

  • 3. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
    Beyer BC, Heiss MM, Simon EH, Gruetzner KU, Babic R, Jauch KW, Schildberg FW, Allgayer H.
    Cancer; 2006 Mar 01; 106(5):1026-35. PubMed ID: 16435385
    [Abstract] [Full Text] [Related]

  • 4. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S.
    Cancer Res; 1998 May 15; 58(10):2234-9. PubMed ID: 9605771
    [Abstract] [Full Text] [Related]

  • 5. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul 15; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 6. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb 15; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 7. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ, Kitson JL, Silvers WK, Mintz B.
    Cancer Res; 1995 Oct 15; 55(20):4681-7. PubMed ID: 7553649
    [Abstract] [Full Text] [Related]

  • 8. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
    Jankun J, Maher VM, McCormick JJ.
    Cancer Res; 1991 Feb 15; 51(4):1221-6. PubMed ID: 1847659
    [Abstract] [Full Text] [Related]

  • 9. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
    De Vries TJ, Mooy CM, Van Balken MR, Luyten GP, Quax PH, Verspaget HW, Weidle UH, Ruiter DJ, Van Muijen GN.
    J Pathol; 1995 Jan 15; 175(1):59-67. PubMed ID: 7891228
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A, Webber MM.
    Clin Cancer Res; 1995 Jul 15; 1(7):747-53. PubMed ID: 9816041
    [Abstract] [Full Text] [Related]

  • 11. The fibrinolytic system in neoplasia.
    Bell WR.
    Semin Thromb Hemost; 1996 Jul 15; 22(6):459-78. PubMed ID: 9122711
    [Abstract] [Full Text] [Related]

  • 12. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
    Piedagnel R, Tiger Y, Lelongt B, Ronco PM.
    J Cell Physiol; 2006 Feb 15; 206(2):394-401. PubMed ID: 16155905
    [Abstract] [Full Text] [Related]

  • 13. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression.
    Robert C, Bolon I, Gazzeri S, Veyrenc S, Brambilla C, Brambilla E.
    Clin Cancer Res; 1999 Aug 15; 5(8):2094-102. PubMed ID: 10473092
    [Abstract] [Full Text] [Related]

  • 14. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
    Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P.
    J Pathol; 2006 Apr 15; 208(5):673-85. PubMed ID: 16450333
    [Abstract] [Full Text] [Related]

  • 15. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 15; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S, Fukao H, Okada K, Matsuo O.
    Thromb Res; 2004 Aug 15; 113(1):41-9. PubMed ID: 15081564
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.